Le Lézard
Classified in: Covid-19 virus

Global Viral Inactivation Market Trajectory & Analytics Report 2020: Kits & Reagents, Systems, Services, Vaccines and Therapeutics, Stem Cell, Blood, Tissue & Cellular and Gene Therapy - ResearchAndMarkets.com


The "Viral Inactivation - Global Market Trajectory & Analytics" report has been added to ResearchAndMarkets.com's offering.

Global Viral Inactivation Market to Reach $951.1 Million by 2027

Amid the COVID-19 crisis, the global market for Viral Inactivation estimated at US$443.1 Million in the year 2020, is projected to reach a revised size of US$951.1 Million by 2027, growing at a CAGR of 11.5% over the analysis period 2020-2027.

Kits & Reagents, one of the segments analyzed in the report, is projected to record a 11.5% CAGR and reach US$549.3 Million by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Systems segment is readjusted to a revised 12.1% CAGR for the next 7-year period.

The U. S. Market is Estimated at $130.7 Million, While China is Forecast to Grow at 11.1% CAGR

The Viral Inactivation market in the U. S. is estimated at US$130.7 Million in the year 2020. China, the world's second largest economy, is forecast to reach a projected market size of US$166.8 Million by the year 2027 trailing a CAGR of 11.1% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 10.2% and 9.8% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 8.4% CAGR.

Services Segment to Record 10.8% CAGR

In the global Services segment, USA, Canada, Japan, China and Europe will drive the 10.6% CAGR estimated for this segment. These regional markets accounting for a combined market size of US$57.2 Million in the year 2020 will reach a projected size of US$115.8 Million by the close of the analysis period. China will remain among the fastest growing in this cluster of regional markets. Led by countries such as Australia, India, and South Korea, the market in Asia-Pacific is forecast to reach US$112.3 Million by the year 2027.

The report presents concise insights into how the pandemic has impacted production and the buy side for 2020 and 2021. A short-term phased recovery by key geography is also addressed.

Competitors identified in this market include, among others:

Key Topics Covered:

I. INTRODUCTION, METHODOLOGY & REPORT SCOPE

II. EXECUTIVE SUMMARY

1. MARKET OVERVIEW

2. FOCUS ON SELECT PLAYERS

3. MARKET TRENDS & DRIVERS

4. GLOBAL MARKET PERSPECTIVE

III. MARKET ANALYSIS

GEOGRAPHIC MARKET ANALYSIS

IV. COMPETITION

For more information about this report visit https://www.researchandmarkets.com/r/nr1p16


These press releases may also interest you

at 18:00
Voxtur Engages ICP Securities Inc. for Automated Market Making Services
Voxtur Analytics Corp. , a North American technology company creating a more transparent and accessible real estate lending ecosystem, is pleased to announce that it has engaged the services of ICP Securities Inc. ("ICP") to provide automated market...

at 18:00
Portland General Electric declares dividend
On April 19, 2024, the board of directors of Portland General Electric Company declared a quarterly common stock dividend of $0.50 per share, representing an increase of 5.3%, or $0.10 per share, on an annualized basis. The company's dividend is...

at 17:52
ADYTON RESOURCES CORPORATION ANNOUNCES CLOSING OF NON-BROKERED PRIVATE PLACEMENT
Adyton Resources Corporation  ("Adyton" or the "Company") announces it has closed its previously announced non-brokered private placement offering, pursuant to which it has issued 50,000,000 common shares of the Company ("Shares") at a price of...

at 17:20
NCPDP's National Facilitator Model Pilot Project Enters Second Phase
Building on a successful phase one in which STChealth proved that the Universal Patient Identifier (UPI)?powered by Experian Health's Universal Identity Manager (UIM) and NCPDP Standardstm?can accurately identify patients across multiple datasets in...

at 17:00
Lion Group Holding Announced Receipt of Nasdaq Listing Delinquency Notice
Lion Group Holding Ltd. ("Lion" or "the Company") , the operator of an all-in-one trading platform that offers a wide spectrum of products and services, today announced that on April 18, 2024, it received a delinquency notification letter from the...

at 16:30
Cosmos Health Receives Nasdaq Notice on Late Filing of Its Form 10-K
Cosmos Health Inc. ("Cosmos Health" or the "Company'') , a diversified, vertically integrated global healthcare group engaged in innovative R&D, owner of proprietary pharmaceutical and nutraceutical brands, manufacturer and distributor...

More news about Covid-19 virus...


News published on and distributed by: